⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Jose Lares-GuiaMD

General Practice · New York, NY 10014

NPI: 1902030869

Share:

32

🟠 Elevated

Risk Flags

Extreme cost outlier (population + peer)High brand-name preferenceElevated long-acting opioid rateElevated antipsychotic prescribing (65+)Extreme fills per patient

Risk indicators are statistical patterns, not allegations. Learn more

5,791

Total Claims

$4.7M

Drug Cost

93

Beneficiaries

$50K

Cost/Patient

Risk Score Breakdown 32/100

Low (0)Moderate (15)Elevated (30)High (50+)
Cost per patient outlier+10
Elderly antipsychotic prescribing+5
High fills per patient+5
Brand-name preference+4
Long-acting opioid rate+4

Score components are additive. Read full methodology

Peer Comparison vs. 7,389 General Practice providers

-16%

Opioid rate vs peers

2.1% vs 2.5% avg

+4358%

Cost per patient vs peers

$50K vs $1,128 avg

+306%

Brand preference vs peers

34.1% vs 8.4% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

💰

Cost per patient is 4358% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

2.1%

Opioid Rate

120

Opioid Claims

$4,911

Opioid Cost

10.8%

Long-Acting Rate

Brand vs Generic

66% generic

Brand: 1,967 claims · $4.3M

Generic: 3,799 claims · $411K

Patient Profile

68

Avg Age

13%

Female

1.47

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About